Cite
Peche VS, Holak TA, Burgute BD, et al. Erratum to: Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cell Mol Life Sci. 2017;74(21):4045doi: 10.1007/s00018-017-2630-x.
Peche, V. S., Holak, T. A., Burgute, B. D., Kosmas, K., Kale, S. P., Wunderlich, F. T., Elhamine, F., Stehle, R., Pfitzer, G., Nohroudi, K., Addicks, K., Stöckigt, F., Schrickel, J. W., Gallinger, J., Schleicher, M., & Noegel, A. A. (2017). Erratum to: Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cellular and molecular life sciences : CMLS, 74(21), 4045. https://doi.org/10.1007/s00018-017-2630-x
Peche, Vivek S, et al. "Erratum to: Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy." Cellular and molecular life sciences : CMLS vol. 74,21 (2017): 4045. doi: https://doi.org/10.1007/s00018-017-2630-x
Peche VS, Holak TA, Burgute BD, Kosmas K, Kale SP, Wunderlich FT, Elhamine F, Stehle R, Pfitzer G, Nohroudi K, Addicks K, Stöckigt F, Schrickel JW, Gallinger J, Schleicher M, Noegel AA. Erratum to: Ablation of cyclase-associated protein 2 (CAP2) leads to cardiomyopathy. Cell Mol Life Sci. 2017 Nov;74(21):4045. doi: 10.1007/s00018-017-2630-x. PMID: 28852764.
Copy
Download .nbib